Company
Telesis Bio
Empowering researchers to accelerate discovery
Also known as Telesis Bio, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- San Diego, California, United States
- Customers
- life sciences industry customers
- Legal name
- Telesis Bio, Inc.
- telesisbio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Telesis Bio is transforming how the world builds biology. Our flagship Gibson SOLA® platform enables on-demand, high-fidelity DNA and mRNA synthesis directly within customer labs—eliminating delays and constraints from traditional outsourcing. By combining enzymatic synthesis chemistry with standard laboratory automation and intuitive design software, Gibson SOLA gives scientists full control over their build timelines, data, and discovery pipelines.
Funding snapshot
- Total raised
- $28MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Undisclosed, $21M2025-03-18
Funding rounds
- Round, 2025
- $21M2025-03-18, Company stated
- Round, 2023
- $28M2023-06-05, SEC form D sold, 4 investors
Products
- Hardware
- BioXp platform
- Hardware
- Gibson SOLA
Loading relationship preview